335 related articles for article (PubMed ID: 22912574)
1. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
Schnell G; Loo YM; Marcotrigiano J; Gale M
PLoS Pathog; 2012; 8(8):e1002839. PubMed ID: 22912574
[TBL] [Abstract][Full Text] [Related]
2. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
Saito T; Owen DM; Jiang F; Marcotrigiano J; Gale M
Nature; 2008 Jul; 454(7203):523-7. PubMed ID: 18548002
[TBL] [Abstract][Full Text] [Related]
4. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.
Malathi K; Saito T; Crochet N; Barton DJ; Gale M; Silverman RH
RNA; 2010 Nov; 16(11):2108-19. PubMed ID: 20833746
[TBL] [Abstract][Full Text] [Related]
5. RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.
Ireton RC; Wilkins C; Gale M
Methods Mol Biol; 2017; 1656():119-129. PubMed ID: 28808965
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.
Uzri D; Gehrke L
J Virol; 2009 May; 83(9):4174-84. PubMed ID: 19224987
[TBL] [Abstract][Full Text] [Related]
7. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
Oshiumi H; Miyashita M; Matsumoto M; Seya T
PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
[TBL] [Abstract][Full Text] [Related]
8. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
[TBL] [Abstract][Full Text] [Related]
9. RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.
Durbin AF; Wang C; Marcotrigiano J; Gehrke L
mBio; 2016 Sep; 7(5):. PubMed ID: 27651356
[TBL] [Abstract][Full Text] [Related]
10. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
11. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
Horner SM; Park HS; Gale M
J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of RNA recognition and activation by innate immune receptor RIG-I.
Jiang F; Ramanathan A; Miller MT; Tang GQ; Gale M; Patel SS; Marcotrigiano J
Nature; 2011 Sep; 479(7373):423-7. PubMed ID: 21947008
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.
Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB
mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454
[TBL] [Abstract][Full Text] [Related]
14. [RIG-I mediated hepatic innate immune signaling that controls HCV infection].
Saito T; Gale M
Uirusu; 2008 Dec; 58(2):105-15. PubMed ID: 19374189
[TBL] [Abstract][Full Text] [Related]
15. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
16. RIG-I in RNA virus recognition.
Kell AM; Gale M
Virology; 2015 May; 479-480():110-21. PubMed ID: 25749629
[TBL] [Abstract][Full Text] [Related]
17. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
Chiang C; Beljanski V; Yin K; Olagnier D; Ben Yebdri F; Steel C; Goulet ML; DeFilippis VR; Streblow DN; Haddad EK; Trautmann L; Ross T; Lin R; Hiscott J
J Virol; 2015 Aug; 89(15):8011-25. PubMed ID: 26018150
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
19. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
20. Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity.
Errett JS; Gale M
Virol Sin; 2015 Jun; 30(3):163-73. PubMed ID: 25997992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
